Primulagenin A is a potent inverse agonist of the nuclear receptor RAR-related orphan receptor gamma (RORγ)
Schwarz, P. F.; Perhal, A. F.; Preglej, T.; Breit, L.; Schmetterer, K. G.; Grienke, U.; Janneschütz, J.; Chen, Y.; Rochel, N.; Kirchmair, J.; Schützenmeister, N.; Rollinger, J. M.; Bonelli, M.; Dirsch, V. M.
Show abstract
Throughout history, herbal medicines and natural products have played a crucial role as therapeutics for humans, yet their molecular mechanisms of action often remain elusive. Here, we ask whether primulagenin A (PGA) from the traditionally used herbal substance Primula root, acts via the nuclear receptor ROR{gamma}, a key regulator of pro-inflammatory Th17 cells, which are linked to autoimmune diseases like psoriasis. Luciferase assays revealed a high potency (IC50 ~100 nM) and efficacy (Imax ~ 90%) of PGA as an inverse agonist of ROR{gamma}. To ensure sufficient supply, we established methods to isolate and synthesize PGA. Its binding to the human ROR{gamma} ligand binding domain was confirmed by nano differential scanning fluorimetry, and a structure-activity relationship was proposed by docking and site-directed mutagenesis. PGA downregulated ROR{gamma} target gene expression and inhibited murine and human Th17 differentiation in a concentration-dependent manner. It also reduced the proportion of IL-17A-producing Th17 cells. In this work, we identify PGA as a new, potent, and efficacious inverse agonist of ROR{gamma}, with potential for modulating immune responses in inflammatory and autoimmune diseases.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- benzothiazole scaffold as versatile nicotinamide mimic allowing nanomolar inhibition of different PARP enzymes 97%
- Design and validation of the first family of photo-activatable ligands for melatonin receptors 97%
- Development of a chemical probe to enable characterization of the casein kinase 1γ subfamily 96%
Similar papers in this journal
- Characterization of new highly selective pyrazolopyrimidine inhibitor of CDK7 96%
- Morphing Cholinesterase Inhibitor Amiridine into Multipotent Drugs for the Treatment of Alzheimer's Disease 96%
- Balancing Rigidity and Flexibility: Optimised 4-(Hexyloxy)benzoate Antagonists with Enhanced Affinity and Tuneable Duration at Muscarinic Receptors 95%
Similar papers in this journal
- Thymoquinone-Protoflavone Hybrid Molecules as Potential Antitumor Agents 97%
- 17-Oxime ethers of oxidized ecdysteroid derivatives modulate oxidative stress in human brain endothelial cells and dose-dependently might protect or damage the blood-brain barrier 96%
- The edible seaweed Laminaria japonica contains cholesterol analogues that inhibit Lipid Peroxidation and Cyclooxygenase Enzymes 96%
Similar papers in this journal
- Modulation of endogenous opioid signaling by inhibitors of puromycin sensitive aminopeptidase 97%
- Shifting the selectivity of pyridopyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily 97%
- Exploring thienothiadiazine dioxides as isosteric analogues of benzo- and pyridothiadiazine dioxides in the search of new AMPA and kainate receptor positive allosteric modulators 97%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.